Twenty Years' Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center
Recruiting now
Conditions studied: Testicular Cancer
In brief
The aim of this study is to evaluate the oncologic and functional outcomes of RPLND as primary treatment (stage I and IIA-IIB with negative markers) or of residual masses after chemotherapy (PC-RPLND) in the treatment of patients with seminomatous and non-seminomatous. In order to evaluate the role and the͛clinical impact of different surgical techniques of RPLND will be included patients treated with open, laparoscopic, and robot-assisted techniques
Key facts
- Study ID
- NCT06806917
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 65
- Starts
- 2021-12-01
- Expected to finish
- 2031-10-31
- Last updated by the study team
- 2025-02-04
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Aged ≥ 18 years
- RPLND of residual mass after chemotherapy in patient with testicular neoplasm seminomatous or nonseminomatous performed by open, laparoscopic, or robotic technique
- Primary RPLND for seminomatous or nonseminomatous testicular neoplasm of stage I or IIA-IIB with negative markers performed with open, laparoscopic or robotic technique
- RPLND performed by open, laparoscopic, or robotic technique for the treatment of tumors seminomatous or nonseminomatous chemiorefractory testicular tumors progressing after I and II line of chemotherapy
- Acquisition of informed consent
You may not qualify if…
- Patient with comorbidities with contraindication to surgery
- Hemorrhagic diathesis
- RETROSPECTIVE PHASE. Patients with the same inclusion and exclusion criteria as in the prospective phase and already undergoing RPLND surgery with open, laparoscopic, or robotic technique from January 2000 to December 2020 in the͛framework of the normal course of care with a minimum follow-up of 12 months. (estimated to include approximately 120 patients).
Where it is running
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (enrolling)
- UO di Chirurgia Urologica della Fondazione IRCCS Istituto Nazionale dei Tumori di Milano — Milan, Italy, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.